|
Acute coronary syndromes
Citations 51-60 of 961 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Is It Time to Treat Depression in Patients With Cardiovascular Disease?
- William Whang and Karina W. Davidson
Circulation published June 29, 2009, doi:10.1161/CIRCULATIONAHA.109.881987
[Abstract]
- Interventional Cardiology
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
- Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation 2009;119:3101-3109; published online before print as doi:10.1161/CIRCULATIONAHA.108.793745
[Abstract]
[Full text]
- Articles
Soluble CXCL16 Predicts Long-Term Mortality in Acute Coronary Syndromes
- Anna M. Jansson, Pål Aukrust, Thor Ueland, Camilla Smith, Torbjørn Omland, Marianne Hartford, and Kenneth Caidahl
Circulation published June 15, 2009, doi:10.1161/CIRCULATIONAHA.108.806877
[Abstract]
- Coronary Heart Disease
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
- APPRAISE Steering Committee and Investigators
Circulation 2009;119:2877-2885; published online before print as doi:10.1161/CIRCULATIONAHA.108.832139
[Abstract]
[Full text]
- Articles
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment–Elevation Myocardial Infarction. Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
- Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation published June 8, 2009, doi:10.1161/CIRCULATIONAHA.108.793745
[Abstract]
- Clinician Update
Can We Override Clopidogrel Resistance?
- Ana Pena, Jean-Philippe Collet, Jean-Sébastien Hulot, Johanne Silvain, Olivier Barthélémy, Farzin Beygui, Christian Funck-Brentano, and Gilles Montalescot
Circulation 2009;119:2854-2857, doi:10.1161/CIRCULATIONAHA.108.857722
[Full text]
- Articles
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome. Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
- APPRAISE Steering Committee and Investigators
Circulation published May 26, 2009, doi:10.1161/CIRCULATIONAHA.108.832139
[Abstract]
- Genetics
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
- Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott, Lei Shen, Richard D. Hockett, John T. Brandt, Joseph R. Walker, Elliott M. Antman, William L. Macias, Eugene Braunwald, and Marc S. Sabatine
Circulation 2009;119:2553-2560; published online before print as doi:10.1161/CIRCULATIONAHA.109.851949
[Abstract]
[Full text]
- Resuscitation Science
Improved Patient Survival Using a Modified Resuscitation Protocol for Out-of-Hospital Cardiac Arrest
- Alex G. Garza, Matthew C. Gratton, Joseph A. Salomone, Daniel Lindholm, James McElroy, and Rex Archer
Circulation 2009;119:2597-2605; published online before print as doi:10.1161/CIRCULATIONAHA.108.815621
[Abstract]
[Full text]
- Editorials
Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome: Can Anything Be Done About It?
- Theodore E. Warkentin and Mark A. Crowther
Circulation 2009;119:2420-2422, doi:10.1161/CIRCULATIONAHA.109.858316
[Full text]
|
|
